Vets Now Ltd, the provider of out-of-hours emergency vet care has announced the acquisition of Salus Quality Partnerships (QP), a Health and Safety service provider to the veterinary profession in the UK.
Vets Now says this acquisition will extend the range of its services aimed at improving the quality of life within the profession and supporting practices to run more efficiently.
Vets Now currently runs 50 emergency clinics throughout the country including two referral hospitals in Scotland and the South West of England. In recent years Vets Now has extended its offering to the profession to include business services aimed at supporting vet practices. These services include Lifelearn (Client Education & Compliance), Staff Training Services, RCVS Practice Standards support and Practice Web services.
Salus QP, which has been running for over 18 years, offers veterinary practices information and services to help them comply with Health and Safety legislation and an anaesthetic monitoring service.
Richard Dixon, Founder of Vets Now said: "Our core purpose at Vets Now has always been to improve the lives of vets and pets, and the recent addition of Salus QP will help to do exactly that. The Salus QP team, led by Mark Enright and Alison Clark, have extensive knowledge in their field and crucially they fully understand the issues as they specifically apply to veterinary practices. With Salus QP our aim is to keep it simple and practical, helping practices fulfil their obligations without letting the Health and Safety tail wag the practice dog. I am very much looking forward to working with both Mark and Alison in the future as we take a fresh and common sense approach to Health and Safety in our profession."
Mark Enright said: "Salus QP and Vets Now both share a strong commitment to the veterinary profession and I truly believe that together we will be greater than the sum of our parts. I look forward to a future of innovations and benefits for all, and to continue to form quality partnerships within the veterinary profession."
VetSurgeon.org member Dr Sarah Caney's company, Cat Professional, is conducting a survey of owner experiences of caring for cats with chronic kidney disease and is looking for practices to help recruit participants.
Recruited practices will be given a complimentary print copy of the new client education book 'Caring for a cat with chronic kidney disease' by Dr Sarah Caney and a set of flyers to give out to eligible cat owners.
Owners completing the survey will each receive a complimentary electronic copy of the same book.
The book is aimed at owners and aims to support veterinary recommendations regarding management of this common condition.
To find out more about this survey please visit http://www.catprofessional.com/ or contact Dr Sarah Caney on 07711 390219.
Eurovet Animal Health has launched Marbiflox 10%, a new marbofloxacin preparation for the treatment of respiratory infections in cattle and pigs.
Eurovet says the product can be used flexibly to provide a single dose treatment, with a concentration-dependent effect and a relatively short withdrawal period. Marbiflox can be administered intravenously, subcutaneously or intramuscularly in cattle or intramuscularly in pigs.
The main indications, with reference to good prescribing practice, are for the treatment of respiratory infections caused by sensitive strains of Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni and acute forms of mastitis induced by marbofloxacin-sensitive Escherichia coli strains, during lactation. In pigs the main indication is in the treatment of MMA (metritis mastitis agalactia syndrome).
Further information about Marbiflox and the complete Eurovet range of products is available from Eurovet Animal Health. www.eurovet-ah.co.uk/.
WebLeC has launched a monthly online equine CPD service.
One hour live interactive sessions will take place every third Thursday at 7:30 pm. A single meeting costs £30 plus VAT, or savings can be made by taking out a flexible subscription that allows the user to choose any 12 meetings for the cost of 10 over a period of up to 24 months.
The next meeting is on 22nd September and is entitled: Colic Decision making: When to wake up the surgeon and what pain control to use. The presenter is Debra Archer form the University of Liverpool. Further details and registration links can be found at: http://www.ledstonequine.co.uk/weblec_lectures/colic.html
In addition, a recording of WebLeC's 6th meeting, which was held in partnership with BEVA and the VDS and dealt with the new guidelines and forms for pre-purchase examinations of horses, is now available to view free online at: www.bitly.com/weblecbevaPPE. Use the password: b3va to get access, and you will receive a CPD certificate if you fill in the registration form.
WebLeC has also been asked to host BEVA's online CPD and will be announcing further details of their meetings soon.
MSD Animal Health has launched Zuprevo Cattle, which contains a novel antibiotic molecule to help combat bovine respiratory disease (BRD).
Zuprevo Cattle contains the active ingredient tildipirosin (180mg/ml), a new 16-membered, tribasic macrolide unique to animal health. It is licensed for the treatment and prevention of BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni.
According to MSD Animal Health livestock veterinary adviser Paul Williams MRCVS, the new product works extremely quickly in the animal, as well as offering the longest duration of activity in the lungs of all the macrolide antibiotics currently on the market. He says it is also extremely convenient to use: "Zuprevo is readily absorbed by the animal, reaching peak plasma concentrations within 23 minutes of injection. Zuprevo is readily distributed around the body and reaches lung concentration well above MIC90 for all of the three BRD target pathogens within four hours of administration. In addition, it maintains lung concentration above the MIC90 for up to 28 days, which will appeal to many practitioners."
Paul says that it is Zuprevo's 16-membered, tribasic macrolide structure that allows it to deliver these significant pharmacological benefits for the management of BRD in cattle: "Zuprevo works by diffusing into the bacterial cell where its binding action inhibits protein synthesis of the bacterial ribosome. Its unique 16-membered, tribasic structure enables enhanced penetration of the bacterial cell wall, as well as having the ability to bypass some potential bacterial resistance mechanisms."
Paul says Zuprevo also offers vets and their farmer clients important practical usage advantages: "Zuprevo is an easily syringeable solution for injection available in convenient 20ml, 50ml and 100ml vial sizes to suit different usage requirements. At a dose rate of 1ml/45kg, it offers the lowest macrolide dose volume per kg of bodyweight. At 47 days, Zuprevo also has the shortest macrolide meat withdrawal period."
Further information on this new macrolide antibiotic is available from the MSD Animal Health territory managers or by calling the company's Veterinary Services Group on 01908 685685.
Ceva Animal Health has added a new presentation to its Cardio Academy CPD website, entitled: Echocardiography: Common Views.
In the 30 minute multimedia presentation, cardiology specialist Anne French discusses the most common echocardiographic views used in the diagnosis of the cardiac patient.
Veterinary professionals can then receive a CPD certificate by completing a quiz about the session.
In addition, you can still access the the first five sessions, covering the Pathophysiology of Mitral Valve Disease, by Adrian Boswood, Clinical Examination of the Cardiac Dog, by Gérard Le Bobinnec and three sessions discussing Thoracic X-rays by Nicole Van Israël.
For further information, please contact your local Ceva account manager.
Woodley Equipment has become the UK distributor for the full portfolio of SpotChem products from Japanese manufacturer, Arkray.
The range of products includes:
For more information about the new SpotChem analysers, visit: www.woodleyequipment.com/, email: sales@woodleyequipment.com or call on +44(0)1204 669033.
The Small Animal Medicine Society (SAMSOC) and the BSAVA have together produced a new poster containing guidelines for the appropriate use of antibiotics in practice.
In recent years, alongside wider recognition of resistant bacteria such as MRSA in animals, the veterinary profession's use of antibiotics has been under the spotlight as a possible factor contributing to the increasing prevalence of bacterial resistance seen in human patients. Veterinary surgeons are faced with the dual problem of treating more and more resistant bacterial infections, whilst the threat of withdrawal of the right to prescribe certain antibiotics hangs over the profession.
SAMSoc and the BSAVA say they feel the time has come for the veterinary profession to take a coordinated responsible approach to its prescribing practices.
Ian Battersby of the Small Animal Medicine Society (SAMSoc) has sought to address the need for rational guidelines for the most appropriate antibiotics, for the correct duration, to maximise clinical efficacy but minimise selection of resistant bacteria. Collaboration with BSAVA resulted in a set of helpful prescribing guidelines in poster form, being sent to members of both associations. A limited number of copies will also be available from the BSAVA Balcony at Congress 2012, and BSAVA has dedicated the October issue of its membership magazine, companion, to the subject.
Ian said: "Of course these PROTECT guidelines are suggestions based on current knowledge and in the future we hope they will be further refined as our experience grows. This is an evolving situation and hopefully more work will be undertaken, in particular looking at treatment durations, allowing further refinement and optimization of practice policies. The key principles are that by implementing a prescribing protocol in our practices we are treating our prescribing privileges responsibly and maximizing the efficacy of the presently available agents for the benefit of both veterinary and human patients now and in the future.
"I would like to particularly thank everyone who has helped with this project; Andrew Jagoe, Professor Ian Ramsey, Tom Maddox, Jon Camillari, Alison Woodward and Dr Tim Nuttall, and BSAVA for facilitating the production of the poster".
The NOAH Code of Practice Committee, chaired by Mr Guy Tritton, has found Dechra Veterinary Products in breach of three items of the NOAH Code, following a complaint.
The complaint related to an advertisement and detailer promoting Felimazole with the wording "Are you taking a heavy-handed approach to hyperthyroidism?" and "with Felimazole, you don't have to!"
The Committee took the view that by implication this referred to Vidalta because Vidalta is the only other licensed oral treatment on the market for hyperthyroidism.
As a result, the Committee found both promotions in breach of Clause 4.3 because of the implication that Vidalta is less safe than Felimazole.
The Committee did not consider the promotions disparaged the manufacturer as there is no evidence to show it is unsafe.
The Committee also found that the table in the detailer (page 4) suggesting that one dosage of 5 mg per day of Felimazole has the same efficacy as two doses of 2.5 mg, (which is contrary to the dosing statement within the SPC: "If, for reasons of compliance, once daily dosing with a 5 mg tablet is preferable, then this is acceptable although reduced efficacy can be expected compared to a twice daily regime.") was misleading, contrary to Clause 4.3 of the Code.
Full details of the Committee's rulings are on the NOAH website at www.noah.co.uk/code. The full report of this particular case will be available shortly.
The Veterinary Marketing Association has 10 tickets available for its annual debate being held at the House of Lords on Tuesday October 12th, this year entitled: Internet Pharmacies - Opportunity or Threat?
The debate will be chaired by Professor Sandy Trees, and the panel will comprise:
The debate kicks off at 10:30am, and is followed by lunch at 12:30pm on the famous terrace, overlooking the Thames.
VetSurgeon members may buy tickets at the lower VMA member price of £120 + VAT, which includes the champagne reception and three course lunch with wine.
Click here for more information.
Carl Padgett has been elected President of the British Veterinary Association for 2011/2012.
Carl graduated from Glasgow University in 1989 and spent most of his career as a large animal practitioner. He is now a director of Bay Vets Ltd in Lancaster, and has particular interests in cattle health, production and welfare, veterinary politics and the role the profession has to play in the wider livestock industry and the companion animal world.
A former president of the British Cattle Veterinary Association (BCVA) and recent Chairman of Trustees of the BVA Animal Welfare Foundation, Carl has been involved in veterinary politics for over 15 years.
Carl said: "My representative roles for BVA, and prior to that BCVA, have enabled me to understand and realise my interest in the veterinary profession: ensuring the profession has a voice and our place in society is valued.
"Our multi-disciplinary education and training places the profession in a unique position to deliver a healthy future at many levels: representing the health and welfare of animals committed to our care, protecting the consumer by ensuring food safety and security at national and international levels by working within the agricultural world and ensuring public health in a variety of ways. Vets are not just part of the leisure industry making animals better; we fill a much wider role in underpinning society and its contact with animals at all levels."And so to the future. Although we do indeed live in a changing world, many of the challenges we face as a profession continue through from one President to the next, as they span beyond the year-long term of office. Over the last couple of years BVA has made a lot of progress on a number of policy issues and, in some instances, our lobbying efforts have paid off with Government announcements and new legislation reflecting our endeavours. Looking ahead, much of the coming year will be about putting those policies into practice, and that's why the theme of my presidential year will be 'Delivering a healthy future'.
"I am proud and honoured to be elected BVA President to continue serving the membership as part of the BVA Officer team."
Peter Harlech Jones was elected BVA President-elect for 2011/2012 at the same time.
The RCVS Charitable Trust is offering up to 10 grants worth around £500 each, to support UK veterinary surgeons looking to pursue themes of clinical or non-clinical research involving short-term visits to veterinary or medical centres, or research institutes, outside the UK.
The Travel Awards are open to registered members of the RCVS, as well as to candidates registered for a PhD at a UK veterinary school. The awards are available for up to 12 months from the award date, and awards cannot be made for projects taking place before 31 October 2011.
The successful candidates will be asked to submit an article to the veterinary press and provide the Trust with a diary record including photographs, and/or short video.
All applications must be received by 5pm on Monday 31 October 2011.
Further information including full application criteria, is available from www.rcvstrust.org.uk/grants/
Alternative, contact grants@rcvstrust.org.uk or call 0207 202 0741.
Pfizer is giving away a free equine weigh tape with every purchase of Equest & Equest Pramox (while stocks last), to help encourage accurate treatment against encysted small redworms this season.
According to the company, Equest & Equest Pramox are the only wormers in the UK that treat encysted small redworm in a single dose. Using a weigh tape to work out their horse's weight will help your clients avoid under dosing, which increases the risk of resistance development.
Pfizer says small redworms are the most common worms found in horses today. They can pose a very serious health risk to horses and it's important for owners to make sure that they are treated properly during the autumn or early winter.
Small redworms can grow up to 2.5cm in length and are thin and reddish in colour. Small redworm eggs are passed in the faeces and then hatch on pasture and continue to develop into more advanced larval stages before being ingested by the horse as it grazes. The larvae burrow deeply into the wall of the gut where they encyst and may account for up to 90% of the redworm burden in the horse1. Encysted small redworm will not show up in a Faecal Worm Egg Count - even if the horse has shown a negative or low count it could still be harbouring several million encysted small redworms2.
Encysted small redworms can remain dormant inside a horse for up to two years, but they usually 'wake-up' in late winter or early spring, developing and emerging from the gut wall all at the same time. In severe infestations mass emergence can lead to a disease syndrome known as 'larval cyathostominosis', causing diarrhoea and colic with up to a 50% mortality rate3. Young horses of less than six years of age can often be at higher risk of the disease3 but small redworm can cause life-threatening illness at any time of year and in any age of horse.
Ben Gaskell, Pfizer's veterinary adviser said: "Treating encysted small redworms successfully in the late autumn or early winter is important to avoid the risk of larval cyathostominosis. It's important to advise your customers to choose a product that is licensed to treat the worms they are targeting and that they give the correct dose, by weighing their horse beforehand, as this will help preserve the efficacy of the drug used."
Pfizer's Does your wormer measure up campaign is backed with point of sale materials and a media campaign. To receive a free weigh tape, valued at £7 your clients need to buy a tube of Equest or Equest Pramox, fill in an application form and send Pfizer the batch and expiry flap from the pack. Pfizer will then send them a FREE Weigh Tape while stocks last.
For further information contact your Pfizer Account Manager.
References
1. Bairden K. et al (2001) Veterinary Record 148, 138-1412. Dowdall S.M.J. et al (2002) Veterinary Parasitology 106, 225‑2423. McWilliam H. et al (2010) International Journal for Parasitology 40, 265-275
A survey of 246 veterinary surgeons and nurses attending a lunch and learn webinar sponsored by Supreme Petfoods has revealed that they rate high fibre as the most important factor in making a recommendation for rabbit or guinea pig food.
High fibre was the top factor for 53% of respondents and rated as being much more important than monocomponent kibbles (27%), or a recommendation by an exotics expert (18%).
Supreme says it has addressed this concern by increasing the fibre content of its Science Selective Rabbit food to 23% fibre - the highest of any concentrate for small furries in the UK. The new VetCarePlus range, based on the monoforage technology developed by the company, contains up to 34% fibre. Fibre is vital for small furries, playing an active role in gastro intestinal health, dental health, weight management and behavioural factors.
The survey also revealed that vets and nurses are feeling optimistic about the impact of small furries on veterinary practice. 70% of respondents felt that, even in the face of the recent recession, small furries/exotics had made a growing contribution to their business profits over the last five years and 90% felt that there was potential for them to make an even bigger contribution to practice profits in the future. The biggest barrier to more small pets being brought forward for treatment was felt to be the cost of treatment relative to the cost of the pet - 55% felt that this was the most significant stumbling block - but another 45% felt that lack of education and an inability to recognise illness were the main factors.
Supreme's Marketing Manager Claire Hamblion has recently launched a trial programme in a limited number of practices to provide the tools needed to help grow the small pets sector. She said: "Our experience to date indicates that having the right tools and providing a warm welcome to owners of small furries that projects a willingness to treat them, can make a difference. We would love to hear more from those who have successfully grown this part of their business and those who are looking to expand their capabilities in this exciting area." Interested parties, or those who would like to pre-register for the further roll out of Supreme's business programme can send an email with their contact details to b2b@supremepetfoods.com.
The company says it has been delighted by the positive response to its lunch and learn webinar format, and more events are being scheduled for the winter months. Those interested in attending future events, or receiving educational material, can register their interest by email at cpd@supremepetfoods.com to receive priority notification of dates and availability.
Norbrook has launched a new iPhone app designed to give veterinary professionals essential pharmaceutical product information at the touch of a button.
The Norbrook Veterinary Excellence Tool includes information on the company's full range of animal health medicines including pharmaceutical presentation, uses, dosage and administration, withdrawal periods, contraindications & warnings and pharmaceutical precautions.
Mr Jorge Rodrigues, General Manager at Norbrook said: "Norbrook is committed to providing the best possible service to our customers. Time is a precious commodity for veterinary professionals and with the range of products on the market it can be very time-consuming to access essential product information. We have designed the Norbrook VET app to give our customers a quick and easy reference tool for all our products with the facility to filter searches for product information by species, category or brand. And of course the beauty of the iPhone app is that the information is accessible anytime, anywhere so if a customer is out at a client's premises, in their practice or at home, the information is readily available."
The Norbrook VET app also has a facility which will keep users up-to-date with relevant industry and company news and a dedicated Contact Us section which will allow customers better communication channels with the company.
Katie Norton, Web SEO Marketing Co-ordinator said: "It is our intention that the Norbrook VET app will become a key communication channel with our customers. The app will be updated regularly and we will continue to add new features to enhance the service we offer to our valued customers."
The Norbrook VET iPhone App is available to download direct from the iTunes store.
The BSAVA reports that within 20 minutes of the opening of enrolment for its Medicine and Surgery certificates at 9:00am yesterday, both courses were filled and a waiting list had been established.
According to the BSAVA, interest in the courses had been flooding in over recent months, however the number of applications still surprised the Education team, led by Dr Frances Barr.
She said: "There was a lot of confidence in this programme from the start, and we had lots of people requesting information, but until yesterday we did not know for certain that we would meet the maximum number of 30 delegates on each Certificate. So to have a waiting list and pre-registration requests for 2013 is fantastic. As veterinary professionals we want to strive for clinical excellence, to have our achievements recognised, and be encouraged and supported on the way there. This is what BSAVA aims to do with the medicine and surgery certificates".
For more information about all BSAVA CPD visit http://www.bsava.com/ or call 01452 726700.
Parasitologists from ESCCAP (European Scientific Counsel Companion Animal Parasites) have been voicing their concern over the implications of the imminent changes to the UK's DEFRA-run Pet Travel Scheme (PETS).
Under the new regulations, which take effect from Jan 2012, tick control will no longer be mandatory. According to ESCCAP, a recent study has demonstrated that a population of exotic tick species has already become established in the south-east of England1. With up to 15,000 animals travelling under PETS each month, the possibility of exotic ticks (and their associated tick-borne diseases) entering and establishing in the UK becomes increasingly likely. The European Parliament has yet to rule on mandatory tapeworm control. The decision will impact on the future distribution of, and disease threat from, Echinococcus multilocularis.
ESCCAP UK is advising all veterinary surgeons to discuss the risks with their clients and to ensure they make an informed decision about tick control when the new legislation comes into effect.
In addition, the UK branch of ESCCAP is holding a free seminar in Bristol on 28th October to highlight the role that veterinary practices can play in helping clients understand how the changes could impact upon their pet's health.
ESCCAP says the seminar will provide all the information clinicians need to have an informed dialogue with clients. Presentations will provide an overview of the impact of the changes to PETS in relation to rabies, Echinococcus and ticks, as well as advice about how to communicate the information to pet owners and the tools and support available.
Additional support includes ESCCAP UK's website http://www.esccapuk.org.uk/, which offers updates on the PETS situation, guidelines for parasite control programmes and podcasts for veterinary surgeons, nurses and pet owners.
The seminar takes place at Engineers' House, The Promenade, Clifton Down, Bristol BS8 3NB.
To register, telephone: 01684 568998, or email: info@esccapuk.org.uk
Reference1. Smith F D, Ballantyne R, Morgan E R, Wall R (2011) Prevalence, distribution and risk associated with tick infestation of dogs in Great Britain. Medical and Veterinary Entomology. doi: 10.1111/j.1365-2915.2011.00954.x
Merial Animal Health is inviting practitioners to submit original clinical pain management cases for The Previcox & Equioxx European Clinical Case Award for Excellence.
Set up last year, the award recognises excellence in pain management in companion animals and horses. Submitted cases will be evaluated for successful management of pain associated with osteoarthritis, surgery or other conditions in companion animals and horses using firocoxib.
Two winners will be selected and each awarded €1,000 and an invitation to present their clinical case during Merial's next European Pain Management Symposium in 2012, with all travel and accommodation expenses paid.
Open to all veterinary practitioners, the deadline for submission is December 1st 2011. For an application form please email agate.vanopstal@merial.com
CPD Solutions has launched four topic-specific veterinary webinar clubs for the veterinary profession, available to view at www.veterinarywebinars.com.
For veterinary surgeons, there are three clubs, one focussing on neurology, another on orthopaedics, and a final one on small animal practice. There is a fourth webinar club for veterinary nurses and technicians.
Susie Coughlan, Managing Director at CPD Solutions said: "We have given a lot of thought to setting up these clubs so that they reflect what people really need from their CPD. Neurology and orthopaedics are always incredibly popular topics and many vets have told us that they feel that in these subject areas, rapid developments and new techniques can really change their approach to cases."
Each club provides a monthly live webinar, in afternoons or evenings and all webinars are available for club members to view after the live event at their convenience. Susie said: "We decided to limit the available webinars to one a month during the annual membership period because with the best will in the world, many vets and nurses have only a limited time available to spend on CPD and there is very little point in paying for a multitude of webinars that they will never have the time to attend. Part of the appeal of webinars is their low cost and value for money, although we know many vets and nurses put flexibility as to when and where they view as the most exciting attribute of webinar clubs."
CPD Solutions is offering a special launch price of £247 + VAT to anyone who joins a webinar club for one year before 10th October (after which, the price rises to £327 + VAT per club). The offer includes a free CD/DVD which the company says is packed with content relevant to the club topic. All members can also access the full back catalogue of webinars relating to the topic.
For more details or to join a webinar club visit www.veterinarywebinars.com or call 0151 328 0444.
Vetoquinol is launching Cimalgex, a new NSAID for dogs this month.
Cimalgex (cimicoxib) is a new second generation COX-2 inhibitor which can be used for the treatment of pain and inflammation due to osteoarthritis and the management of peri-operative pain associated with orthopaedic and soft tissue surgery, for which it can be given two hours before surgery and continued for 3-7 days post surgery.
Vetoquinol says that an important consideration in treating dogs with osteoarthritis, many of which are geriatric, is that there are no contraindications to using Cimalgex in patients with mild to moderate renal impairment.
According to the company, field trials showed that over 90 per cent of per owners and vets identified that animals experienced excellent analgesia post operatively*.
Available in a chewable, splitable tablet, Cimalgex can be given with or without food.
Vetoquinol says that the excellent tolerability, efficacy profile and ease of use of Cimalgex means that veterinary patients could benefit from pain relief in situations where clinicians are worried about the risks versus the benefits of prescribing a NSAID for pain management.
Further information about assessing pain and decision making when it comes to prescribing NSAIDs, will be presented in a free webinar on 19th October at 8.30pm. To register go to www.thewebinarvet.com/vetoquinol and enter code CIM1.
Reference*E. Grandemange: Field evaluation of the efficacy and the safety of cimicoxib in the relief of peri-operative pain in dogs; 2008, study number n°3008C2F1
Free veterinary careers materials are available from the Royal College of Veterinary Surgeons for vets going back to school to give careers talks.
Freda Andrews, Head of Education said: "We know that, although veterinary surgeons are busy people, they often say yes when schools ask them to give careers talks. "Since September last year we've responded to around 500 requests for our 'Veterinary Science...for all Walks of Life' careers information. If you are giving a talk, these are well worth a look."
Comprising a printed booklet and a series of short videos available online, the careers materials were produced by the RCVS in collaboration with the vet schools and with government funding. They aim to show the variety both in veterinary work, and in vets themselves, to encourage teenagers from all backgrounds to consider aiming for a career in veterinary medicine. The videos can also be watched on the VetCareers channel on YouTube.
Each video features a vet working in a different field within veterinary medicine, and the brochure contains information about different types of veterinary careers, routes into the vet schools, and the entry requirements. Anyone who is in a position to advise aspiring vet students on the university entry requirements needs to be aware that there are now a variety of different routes into vet school, including options for students with vocational qualifications such as BTEC Diplomas, and pre-entry or foundation years aimed at increasing the diversity of the student population.
A new careers leaflet will also shortly be available from the RCVS to encourage would-be veterinary nurses, and will include the new RCVS Level 3 VN Diploma and the mixed-practice route to qualification newly introduced by the RCVS.
Freda said: "Veterinary surgeons can come from all walks of life - as our careers materials show. It's important that the profession reflects the population it serves and for teenagers to have good advice about veterinary careers and how to get into the profession. So, if you're going back to school to encourage the next generation, then get in touch!"
Free hard-copies of the brochure are available by contacting the RCVS Education Department (education@rcvs.org.uk or 020 7202 0791). An interactive version of the booklet can be found at http://www.walksoflife.org.uk/, and individual videos viewed at http://www.youtube.com/vetcareers.
Bayer Animal Health has launched a next generation fluoroquinolone antimicrobial - Veraflox (pradofloxacin) - for the treatment of bacterial infections in cats and dogs.
Bayer Animal Health's marketing manager Dr Markus Edingloh said: "Veraflox, with its molecular compound pradofloxacin, developed exclusively for veterinary medicine, marks a major leap forward in veterinary antibiotic therapy and patient care.
"Veraflox has an enhanced spectrum of antimicrobial activity which encompasses Gram-positive and anaerobic bacteria. In addition, Veraflox has demonstrated high levels of bactericidal activity against target pathogens including activity against dormant bacteria typically found in chronic infections."
For cats, an oral suspension is available in which a fine-grained ion exchange agent binds to the antibiotic, apparently allowing it to pass the cat's taste buds undetected. Bayer says this innovation has been adopted specifically to ensure the product is palatable to cats, and help ensure owner compliance. The oral suspension comes with a syringe with both millilitre and gramme graduations, to help ensure accurate dosing.
Veraflox oral suspension is indicated for the treatment of upper respiratory tract infections, wound infections and abscesses. The 15mg tablet is also licensed in cats for treating upper respiratory tract infections.
Bayer says that in addition to its other indications, Veraflox is also very effective at combatting anaerobic bacteria that play a major role in aggressive bone destruction in canine periodontal disease, and it is the first fluoroquinolone to be licensed in dogs for the adjunctive treatment of severe infections of the gingiva and periodontal tissues.
In addition to its dental claim for dogs, Veraflox is also indicated for the treatment of wound infections, superficial and deep pyoderma, and acute urinary tract infections. It is given to dogs as a once-daily flavoured tablet.
Dr Edingloh added: "The unique chemistry and way in which Veraflox works gives it superior antibacterial activity compared with existing fluoroquinolones. In addition, during field studies, Veraflox was shown to be superior to other leading antibiotic products.
"Pradofloxacin has been proven to have a wide spectrum of activity, outstanding antibacterial activity, and an excellent safety margin. Its pharmacokinetic features ensure this active ingredient can rapidly get to the site of infection, at which it has a great impact on the pathogen population.
"One of the most common reasons for treatment failure where antibiotics are concerned is lack of owner compliance. The availability of Veraflox as an oral suspension with a graded syringe for cats, will enable more accurate dosing, far easier administration and so ensure higher cure rates.
"The launch of Veraflox is the first major advance in its class, since the introduction of Baytril, the first veterinary fluoroquinolone, over 20 years ago. Veraflox provides vets with more predictability, reliability and peace of mind, especially in difficult to treat infections."
For further information on Veraflox, please contact your Bayer representative or call 01635 563000.
The RCVS Veterinary Nurses Council has decided that the College should cease being an awarding body next year, which means it will no longer offer the vocational Level 3 Diploma in Veterinary Nursing.
The College says it will ensure that the Diploma continues to be available by transferring the intellectual property associated with the qualification, such as the question banks and systems, to another larger awarding body, in a move which is likely to take effect for the beginning of the 2012 academic year.
According to the College, this decision reflects recent changes in the regulatory Conditions of Approval for awarding bodies, which it would have been hard for the College to meet while continuing to offer the Diploma cost-effectively. The changes mainly relate to potential conflicts of interest between the College's primary role, as professional regulator that safeguards standards within the veterinary professions, and its role as an awarding body. The standards-setting role includes the regulation of education and training leading to the veterinary and VN registers, and it was felt that the College could no longer exercise this role effectively if it was also an awarding organisation, as it might be suspected of treating its internal qualifications more favourably, or of obstructing competitors.
Although the College says this has not been a problem in the past, the rules are now more stringent, and the costs of setting up a fully independent awarding body would be prohibitive.
The market for the Diploma is also likely to fragment in the future, with three other awarding bodies expressing an interest in offering a Level 3 Diploma. Any reduction in the number of students taking the RCVS Level 3 Diploma would further push up the costs, potentially making the RCVS Awarding Body unviable. A larger awarding body can take advantage of economies of scale across a range of awards in a way that the RCVS cannot.
Colonel Neil Smith, Chairman of the RCVS Awarding Body Board said: "The RCVS has been offering vocational qualifications since 1998 and the decision to cease being an awarding body has not been taken lightly.
"We have taken this decision in order to focus on our core responsibilities of professional regulation and standard setting. However, we remain committed to maintaining the Diploma, which has been carefully developed by the RCVS and the profession. This move ensures that it will stay in safe hands."
The name of the awarding body to which the qualification will be transferred has not yet been announced because the process is not complete. However, the College says it felt it was important to give those involved with the delivery of training as much notice as possible of the change. More information, and the change-over plan, will be released in due course.
Libby Earle, RCVS Head of Veterinary Nursing said: "Our priority will be effecting a smooth transfer for students, Colleges and training practices, and we are confident that the impact of the change will be minimal. Furthermore, it will be a condition of the transfer that the veterinary profession continues to have a say in the future development of the qualification."
Those students still in the process of completing the old NVQ qualifications, the accreditation of which is due to run out in 2013, will continue to be serviced by the RCVS.
As the professional regulator, the College will continue to issue RCVS certificates and badges to those who have successfully completed a registerable qualification - such as an approved vocational qualification run by another awarding body, or an RCVS-recognised veterinary nursing degree.
The Advanced Diploma in Veterinary Nursing will be unaffected by the change as the qualification is awarded by the College under its Royal Charter powers.
Virbac has announced that it is to increase production of cat vaccines at its French plants to help practices in the UK manage a shortfall in supply.
The predicted shortfall follows warnings by other manufacturers of stock shortages of between three and six months.
Virbac, which makes the Feligen RCP, Leucogen and Leucofeligen cat vaccines, says it wants to reassure practices that it will do its utmost to ensure continuity of supply during this period and is urging them to order as usual and not stockpile product, which could exacerbate the problem.
Simon Boulton MRCVS, Product Manager for Virbac's vaccine range, said: "Our priority is to keep stock flowing to our existing customers. With this in mind, we've now ceased to supply wholesalers with our cat vaccines. Once wholesaler stocks have been depleted, we ask customers to contact us directly so that stock can be despatched to them from our own warehouse.
By taking this step, we can manage our own stocks effectively and, while we'll be putting our existing customers first, we also stand ready to help supply the rest of the veterinary sector during this period. As a primary manufacturer of vaccines, we're well placed to react quickly to stock shortages and expect to have significantly increased supply by November."
Practices wanting further information should contact their Virbac Territory Manager. Direct orders to the company should be made by calling Virbac on 01359 243243 and selecting Option Three (Direct Orders).
The RCVS Veterinary Nurses Council has celebrated the 50th anniversary of veterinary nursing at the House of Commons with a call for statutory regulation for the profession.
At a Golden Jubilee event hosted by Mr Roger Gale MP, Veterinary Nurses Council Chairman Liz Branscombe drew attention to the fact that there is no legal protection for the title 'veterinary nurse', despite qualified nurses playing "a unique role in the practice team".
This effectively means that anyone could work in a veterinary practice as a nurse, without taking the three- or four-year training required for Listed or Registered Veterinary Nurses.
Liz said: "We believe that the nation's animals and their owners deserve better than this. And it's not just a question of animal welfare: public health is at risk from the incorrect use of medicines - for example, the well documented development of antimicrobial resistance."
The Veterinary Surgeons Act 1966 was put in place only five years after the introduction of veterinary nurse training and too soon to fully recognise the potential of veterinary nursing as a profession in its own right.
As an interim measure, the RCVS has put in place a non-statutory Register for Veterinary Nurses, to which 86% of eligible nurses have signed up. Registered Veterinary Nurses agree to follow a code of conduct, keep their skills and knowledge up to date and abide by a disciplinary system. However, it is not possible for the College to bar those removed from the Register for serious professional misconduct from working as a veterinary nurse.
The Register also does not address the misuse of the title 'veterinary nurse' by unqualified people.
Liz asked MPs present at the House of Commons reception to sign up to an Early Day Motion tabled by Andrew Rosindell MP, which calls for statutory regulation for the veterinary nursing profession.
Others are urged to sign a petition on the Government's website which has been mounted by the British Veterinary Nursing Association and is supported by the College and the British Veterinary Association: http://epetitions.direct.gov.uk/petitions/18700.
The issues are being considered by the RCVS Veterinary Nurses Legislation Working Party and the group's recommendations will feed into the wider work of the RCVS Legislation Working Party, which will be reporting to the Defra Minister of State in the summer of 2012 with proposals as to how statutory regulation could be provided for a range of veterinary services, including veterinary nursing.